Literature DB >> 31142505

The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity.

Stan van Keulen1,2, Naoki Nishio1, Andrew Birkeland1, Shayan Fakurnejad1, Brock Martin3, Tim Forouzanfar2, Kristen Cunanan4, A Dimitrios Colevas5, Nynke S van den Berg1, Eben Rosenthal6.   

Abstract

PURPOSE: Despite major advancements in surgical oncology, the positive margin rate for primary head and neck cancer resection remains around 15%-30%. In particular, the deep surface margin is the most challenging to adequately assess. Inadequate margins are directly correlated to poor survival, and as such, mitigation of these rates is critical to improve patient outcomes. We have developed an ex vivo imaging strategy that utilizes fluorescence intensity peaks (relative to background signal) of an injected anti-EGFR antibody conjugated to a fluorescent probe to locate potential close or positive margins on the deep surface of the resected tumor specimen. EXPERIMENTAL
DESIGN: Twelve patients with head and neck cancer scheduled for surgery received systemic administration of a tumor-specific contrast-agent (panitumumab-IRDye800CW). After surgical resection, the tumor specimen was imaged using a fluorescence imager. The three highest fluorescence intensity-peaks on the deep surface of the specimen were isolated and correlated to histology to determine the margin distance at these regions.
RESULTS: Relative fluorescence peak intensities identified the closest margin on the deep surface of the specimen within 2.5 minutes. The highest intensity peak consistently (100%) detected the closest margin to the tumor. The difference in tumor margin distance between the first and second highest fluorescence intensity peak averaged 2.1 ± 1.4 mm. The tumor-margin difference between the second and third highest peak averaged 1.6 ± 0.6 mm.
CONCLUSIONS: Fluorescence intensity peaks can identify the region on the specimen where tumor is closest to specimen's edge on the deep surface. This technique could have broad applications in obtaining adequate margins in oncological surgery. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31142505      PMCID: PMC7021202          DOI: 10.1158/1078-0432.CCR-19-0319

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  20 in total

1.  Frozen section analysis of margins for head and neck tumor resections: reduction of sampling errors with a third histologic level.

Authors:  Stephen M Olson; Mohammad Hussaini; James S Lewis
Journal:  Mod Pathol       Date:  2011-01-07       Impact factor: 7.842

2.  Intra-operative frozen section consultation: concepts, applications and limitations.

Authors:  Hasnan Jaafar
Journal:  Malays J Med Sci       Date:  2006-01

3.  Detection of Head and Neck Cancer in Surgical Specimens Using Quantitative Hyperspectral Imaging.

Authors:  Guolan Lu; James V Little; Xu Wang; Hongzheng Zhang; Mihir R Patel; Christopher C Griffith; Mark W El-Deiry; Amy Y Chen; Baowei Fei
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

4.  Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.

Authors:  Eben L Rosenthal; Jason M Warram; Esther de Boer; Thomas K Chung; Melissa L Korb; Margie Brandwein-Gensler; Theresa V Strong; Cecelia E Schmalbach; Anthony B Morlandt; Garima Agarwal; Yolanda E Hartman; William R Carroll; Joshua S Richman; Lisa K Clemons; Lisle M Nabell; Kurt R Zinn
Journal:  Clin Cancer Res       Date:  2015-04-22       Impact factor: 12.531

5.  Intraoperative navigation in complex head and neck resections: indications and limits.

Authors:  S Catanzaro; C Copelli; A Manfuso; K Tewfik; N Pederneschi; L Cassano; R Cocchi
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-09-22       Impact factor: 2.924

6.  Accuracy of frozen sections in assessing margins in oral cancer resection.

Authors:  R A Ord; S Aisner
Journal:  J Oral Maxillofac Surg       Date:  1997-07       Impact factor: 1.895

7.  Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma.

Authors:  Stan van Keulen; Nynke S van den Berg; Naoki Nishio; Andrew Birkeland; Quan Zhou; Guolan Lu; Han-Wei Wang; Lyle Middendorf; Tymour Forouzanfar; Brock A Martin; A Dimitrios Colevas; Eben L Rosenthal
Journal:  Oral Oncol       Date:  2018-11-21       Impact factor: 5.337

8.  A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens.

Authors:  Julia Anne Woolgar; Asterios Triantafyllou
Journal:  Oral Oncol       Date:  2005-08-29       Impact factor: 5.337

9.  The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma.

Authors:  L A Ravasz; P J Slootweg; G J Hordijk; F Smit; I van der Tweel
Journal:  J Craniomaxillofac Surg       Date:  1991-10       Impact factor: 2.078

10.  The effect of the surgical margins on the outcome of patients with head and neck squamous cell carcinoma: single institution experience.

Authors:  Hany Eldeeb; Craig Macmillan; Christine Elwell; Abdulla Hammod
Journal:  Cancer Biol Med       Date:  2012-03       Impact factor: 4.248

View more
  18 in total

1.  New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue.

Authors:  Changjian Li; Jiahui Mi; Yueqi Wang; Zeyu Zhang; Xiaoyong Guo; Jian Zhou; Zhenhua Hu; Jie Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-10-08       Impact factor: 10.057

2.  First Clinical Results of Fluorescence Lifetime-enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes.

Authors:  Rahul Pal; Marisa E Hom; Nynke S van den Berg; Thinzar M Lwin; Yu-Jin Lee; Andrey Prilutskiy; William Faquin; Eric Yang; Srinivas V Saladi; Mark A Varvares; Eben L Rosenthal; Anand T N Kumar
Journal:  Clin Cancer Res       Date:  2022-06-01       Impact factor: 13.801

Review 3.  Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.

Authors:  Roberto N Solis; Dustin A Silverman; Andrew C Birkeland
Journal:  Curr Treat Options Oncol       Date:  2022-02-23

4.  Fluorescent Molecular Imaging Can Improve Intraoperative Sentinel Margin Detection in Oral Squamous Cell Carcinoma.

Authors:  Giri Krishnan; Nynke S van den Berg; Naoki Nishio; Shrey Kapoor; Jaqueline Pei; Laura Freeman; Yu-Jin Lee; Quan Zhou; Stan van Keulen; Shayan Farkurnejad; James Condon; Fred M Baik; Brock A Martin; Eben L Rosenthal
Journal:  J Nucl Med       Date:  2022-01-13       Impact factor: 11.082

5.  Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols.

Authors:  Cheng Wang; Xiaochun Xu; Margaret Folaron; Jason R Gunn; Sassan Hodge; Eunice Y Chen; P Jack Hoopes; Kenneth M Tichauer; Kimberley S Samkoe
Journal:  Mol Imaging Biol       Date:  2021-10-14       Impact factor: 3.484

6.  Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery.

Authors:  Cheng Wang; Xiaochun Xu; Sassan Hodge; Eunice Y Chen; P Jack Hoopes; Kenneth M Tichauer; Kimberley S Samkoe
Journal:  Mol Imaging Biol       Date:  2021-10-12       Impact factor: 3.484

7.  Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.

Authors:  Guolan Lu; Nynke S van den Berg; Brock A Martin; Naoki Nishio; Zachary P Hart; Stan van Keulen; Shayan Fakurnejad; Stefania U Chirita; Roan C Raymundo; Grace Yi; Quan Zhou; George A Fisher; Eben L Rosenthal; George A Poultsides
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05-14

8.  Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody-Dye Conjugate.

Authors:  Naoki Nishio; Nynke S van den Berg; Brock A Martin; Stan van Keulen; Shayan Fakurnejad; Eben L Rosenthal; Katheryne E Wilson
Journal:  J Nucl Med       Date:  2020-10-02       Impact factor: 10.057

9.  Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.

Authors:  Giri Krishnan; Nynke S van den Berg; Naoki Nishio; Georgina Juniper; Jaqueline Pei; Quan Zhou; Guolan Lu; Yu-Jin Lee; Kimberly Ramos; Andrei H Iagaru; Fred M Baik; Alexander D Colevas; Brock A Martin; Eben L Rosenthal
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

10.  Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.

Authors:  Floris Jan Voskuil; Steven Jakob de Jongh; Wouter Tjerk Rudolph Hooghiemstra; Matthijs David Linssen; Pieter Jan Steinkamp; Sebastiaan Antonius Hendrik Johannes de Visscher; Kees-Pieter Schepman; Sjoerd Geert Elias; Gert-Jan Meersma; Pascal Klaas Christiaan Jonker; Jan Johannes Doff; Annelies Jorritsma-Smit; Wouter Bastiaan Nagengast; Bert van der Vegt; Dominic James Robinson; Gooitzen Michell van Dam; Max Johannes Hendrikus Witjes
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.